ask="1.55"
ask_size="5000"
average_daily_volume="1805880"
bid="1.54"
bid_size="700"
book_value="1.37"
change="+0.00"
change_from_200_day_moving_average="-3.85"
change_from_50_day_moving_average="-0.92"
change_from_52_week_high="-6.67"
change_From_52_week_low="0.35"
change_in_percent="+0.00%"
close="1.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.34"
ebitda="-82.29M"
eps_estimate_current_year="-0.21"
eps_estimate_next_quarter="-0.09"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="69786000"
high="1.73"
high_52_weeks="8.22"
last_trade_date="12/30/2016"
last_trade_price="1.55"
last_trade_size="26821"
last_trade_time="4:00pm"
low="1.53"
low_52_weeks="1.20"
market_capitalization="114.97M"
moving_average_200_day="5.40"
moving_average_50_day="2.47"
name="Arrowhead Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="1.80"
open="1.69"
pe_ratio="N/A"
peg_ratio="-1.07"
percent_change_from_200_day_moving_average="-71.30%"
percent_change_from_50_day_moving_average="-37.20%"
percent_change_from_52_week_high="-81.14%"
percent_change_from_52_week_low="+29.17%"
previous_close="1.55"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.13"
price_per_sales="726.12"
revenue="158333.00"
shares_outstanding="74173000"
short_ratio="3.34"
stock_exchange="NMS"
symbol="ARWR"
volume="2667105"
weeks_range_52="1.20 - 8.22"
